Kiniksa Pharmaceuticals International, plc KNSA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's investing cash flow?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported investing cash flow of -$31.92M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's investing cash flow changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's investing cash flow increased by 38.1% year-over-year, from -$51.54M to -$31.92M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's investing cash flow?
- Over 2 years (2022 to 2025), Kiniksa Pharmaceuticals International, plc's investing cash flow has grown at a 383.7% compound annual growth rate (CAGR), from -$8.08M to -$188.99M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.